Chronic lymphocytic leukemia with progressive anemia secondary to development of composite lymphoma.

Eric McGinnisJames T EnglandJeffrey W CraigHabib Moshref Razavi

Published in: Clinical case reports (2020)

Deterioration of hematologic parameters in lymphoma patients is often attributed to disease progression, comorbidities, or treatment effects. Second primary malignancies occur at increased frequency in CLL and must also be considered.

Keyphrases

chronic lymphocytic leukemia
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
multiple sclerosis
prognostic factors
peritoneal dialysis
patient reported outcomes
combination therapy